How Can Your Small Business Benefit From This Knowledge?
So, here’s the story, with all of the big guys making bundles of money on simple speculation regarding the corona virus vaccine. We thought it might be a good idea to keep our subscribers aware and on top of some of the other hopefuls that could very well be your pot of gold at the end of the rainbow. Below is a list of companies that have been working on and have an excellent chance of being first in line in The Race To Cure Corona.
Here’s The Take-a-way You Need To Know
A mix of legacy drug makers and small startups have stepped forward with plans to develop vaccines or treatments that target the infection caused by the novel coronavirus.
COVID-19, which was first detected in December in Wuhan, China, has since sickened nearly 4.6 million people worldwide and killed more than 300,000, as of mid-May.
The Food and Drug Administration has issued two emergency-use authorizations for COVID-19 treatments, including one for hydroxychloroquine sulfate and chloroquine phosphate in March to treat COVID-19 patients and one for Gilead Sciences Inc.’s remdesivir on May 1. No drugs or vaccines have received FDA approval.
Read more of MarketWatch’s coverage of COVID-19.
In the U.S., many of the publicly traded companies that are initiating development have received funding from two organizations: the Biomedical Advanced Research and Development Authority, or BARDA, which is a division of the Department of Health and Human Services, and the National Institute of Allergy and Infectious Diseases, or NIAID, a division of the National Institutes of Health. Some companies have also received funding from Coalition for Epidemic Preparedness Innovations, or CEPI, a global organization based in Oslo that has provided millions of dollars in funding to vaccine makers. Other companies are funding trials by themselves or through life-sciences-company partnerships.
These are some of the companies developing treatments or vaccines in the U.S. for COVID-19, as of early May. (An earlier version of the article included several adjuvant platform technologies that are used to aid the development process and a privately held company, but they have since been removed to focus on public companies.)>
Companies On The Verge Of Discovery
1. Type: Vaccine
Stage: Preclinical
Name: AdCOVID
